BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

CLEVELAND BIOLABS — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

CLEVELAND BIOLABS

via BOOK HILL PARTNERS

1st Quarter (Jan 1 - Mar 31) · 2008Posted Apr 28, 2008Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: CLEVELAND BIOLABS
Description: biotech
Location: New York · United States of America

Registrant

Firm: BOOK HILL PARTNERS
Description: Federal Government Relations
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Defense
biodefense
LobbyistsERIC VAUGHN · mr ROBERT F HOUSMAN
Covered position (ERIC VAUGHN): OMB
Covered position (mr ROBERT F HOUSMAN): Asst Dir, White HOuse Drug Policy

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.